(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Adaptimmune Therapeutics is 2947930
Date | Daily Closing Price | Open | High | Low | Volume |
11 Fri Apr 2025 | 0.22 | 0.24 | 0.24 | 0.20 | 0.522 times |
10 Thu Apr 2025 | 0.22 | 0.24 | 0.24 | 0.21 | 0.205 times |
09 Wed Apr 2025 | 0.23 | 0.23 | 0.24 | 0.22 | 0.492 times |
08 Tue Apr 2025 | 0.23 | 0.29 | 0.31 | 0.22 | 0.583 times |
07 Mon Apr 2025 | 0.26 | 0.26 | 0.28 | 0.25 | 0.413 times |
04 Fri Apr 2025 | 0.26 | 0.32 | 0.32 | 0.25 | 0.684 times |
03 Thu Apr 2025 | 0.32 | 0.29 | 0.33 | 0.27 | 1.335 times |
02 Wed Apr 2025 | 0.31 | 0.25 | 0.32 | 0.24 | 2.292 times |
01 Tue Apr 2025 | 0.25 | 0.20 | 0.25 | 0.20 | 2.004 times |
31 Mon Mar 2025 | 0.20 | 0.21 | 0.21 | 0.20 | 0.984 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.2 as stoploss in an intra day buy trade for a target of 0.31. However, stock will show a bearish move below 0.2.
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.20 |
Upside Target | 0.26 |
Upside Target | 0.31 |
Upside Target | 0.33 |
Upside Target | 0.44 |
Upside Target | 0.47 |
Upside Target | 0.49 |
Upside Target | 0.51 |
Upside Target | 0.53 |
Upside Target | 0.54 |
Upside Target | 0.56 |
Upside Target | 0.62 |
Upside Target | 0.67 |
Upside Target | 0.69 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.18 |
Downside Intraday Target | 0.13 |
Upside Intraday Target | 0.29 |
Upside Intraday Target | 0.35 |
Upside Intraday Target | 0.24 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
11 Fri Apr 2025 | 0.22 | 0.26 | 0.31 | 0.20 | 0.304 times |
04 Fri Apr 2025 | 0.26 | 0.21 | 0.33 | 0.20 | 3.671 times |
28 Fri Mar 2025 | 0.21 | 0.31 | 0.31 | 0.20 | 0.273 times |
21 Fri Mar 2025 | 0.29 | 0.45 | 0.47 | 0.26 | 2.971 times |
14 Fri Mar 2025 | 0.45 | 0.48 | 0.49 | 0.44 | 1.263 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
11 Fri Apr 2025 | 0.22 | 0.20 | 0.33 | 0.20 | 0.581 times |
31 Mon Mar 2025 | 0.20 | 0.56 | 0.56 | 0.20 | 2.494 times |
28 Fri Feb 2025 | 0.54 | 0.57 | 0.62 | 0.51 | 0.66 times |
31 Fri Jan 2025 | 0.59 | 0.54 | 0.69 | 0.54 | 0.549 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.27 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.27 and Adaptimmune Therapeutics (ADAP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.